Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-1995	12-1994	12-1993	12-1992	12-1991
Assets
Current Assets
Cash & Cash Equivalents	727	490	1,380	3,780	4,400
Marketable Securities	720	930	750	N/A	N/A
Receivables	820	740	550	750	50
Inventories	1,900	1,340	400	90	110
Other current assets	-1,407	-430	-170	50	50
TOTAL	$2,760	$3,070	$2,910	$4,670	$4,610

Non-Current Assets
PPE Net	1,092	N/A	N/A	N/A	N/A
Other Non-Current Assets	6,000	6,810	0	0	0
TOTAL	$7,092	$6,810	$N/A	$N/A	$N/A

Total Assets	$9,870	$11,190	$3,120	$4,860	$4,770

Liabilities
Current Liabilities
Short Term Debt	280	470	N/A	N/A	N/A
Accounts payable and accrued liabilities	1,430	2,670	280	0	0
Accrued Expenses	900	620	60	N/A	N/A
TOTAL	$4,230	$4,110	$340	$590	$160

Non-Current Liabilities
Other Non-Current Liabilities	1,280	70	0	0	0
TOTAL	$1,320	$360	$N/A	$N/A	$N/A

Total Liabilities	$3,745	$4,470	$340	$590	$160

Shareholders' Equity
Common Shares	6,060	4,660	2,490	15,350	15,350
Retained earnings	-27,030	-18,130	-12,570	-11,080	-10,740
Other shareholders' equity	60	-70	0	-10	-10
TOTAL	$4,300	$6,690	$2,780	$4,260	$4,600

Total Liabilities And Equity	$8,045	$11,160	$3,120	$4,850	$4,760